annual operating expenses:
$604.63M+$158.89M(+35.65%)Summary
- As of today (May 29, 2025), ARWR annual total operating expenses is $604.63 million, with the most recent change of +$158.89 million (+35.65%) on September 30, 2024.
- During the last 3 years, ARWR annual operating expenses has risen by +$317.31 million (+110.44%).
- ARWR annual operating expenses is now at all-time high.
Performance
ARWR Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$161.51M-$2.40M(-1.47%)Summary
- As of today (May 29, 2025), ARWR quarterly total operating expenses is $161.51 million, with the most recent change of -$2.40 million (-1.47%) on March 31, 2025.
- Over the past year, ARWR quarterly operating expenses has increased by +$35.32 million (+27.99%).
- ARWR quarterly operating expenses is now -8.31% below its all-time high of $176.14 million, reached on June 30, 2024.
Performance
ARWR quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ARWR Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.6% | +28.0% |
| 3 y3 years | +110.4% | +46.5% |
| 5 y5 years | +461.9% | +252.9% |
ARWR Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.4% | -8.3% | +64.6% |
| 5 y | 5-year | at high | +461.9% | -8.3% | +272.8% |
| alltime | all time | at high | >+9999.0% | -8.3% | >+9999.0% |
ARWR Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $161.51M(-1.5%) |
| Dec 2024 | - | $163.91M(+1.1%) |
| Sep 2024 | $604.63M(+35.6%) | $162.20M(-7.9%) |
| Jun 2024 | - | $176.14M(+39.6%) |
| Mar 2024 | - | $126.19M(-9.9%) |
| Dec 2023 | - | $140.10M(+12.6%) |
| Sep 2023 | $445.74M(+5.7%) | $124.43M(+5.0%) |
| Jun 2023 | - | $118.53M(+20.8%) |
| Mar 2023 | - | $98.10M(-6.3%) |
| Dec 2022 | - | $104.68M(-9.3%) |
| Sep 2022 | $421.74M(+46.8%) | $115.41M(+9.6%) |
| Jun 2022 | - | $105.32M(-4.5%) |
| Mar 2022 | - | $110.25M(+21.5%) |
| Dec 2021 | - | $90.76M(-12.0%) |
| Sep 2021 | $287.32M(+58.6%) | $103.17M(+32.7%) |
| Jun 2021 | - | $77.76M(+27.4%) |
| Mar 2021 | - | $61.04M(+34.6%) |
| Dec 2020 | - | $45.36M(-21.5%) |
| Sep 2020 | $181.15M(+68.3%) | $57.75M(+33.3%) |
| Jun 2020 | - | $43.32M(-5.3%) |
| Mar 2020 | - | $45.77M(+33.4%) |
| Dec 2019 | - | $34.31M(+1.9%) |
| Sep 2019 | $107.61M(+49.3%) | $33.65M(+39.6%) |
| Jun 2019 | - | $24.10M(-7.8%) |
| Mar 2019 | - | $26.14M(+10.2%) |
| Dec 2018 | - | $23.71M(+5.7%) |
| Sep 2018 | $72.08M(+5.4%) | $22.42M(+34.7%) |
| Jun 2018 | - | $16.65M(+6.1%) |
| Mar 2018 | - | $15.68M(-9.5%) |
| Dec 2017 | - | $17.32M(-8.7%) |
| Sep 2017 | $68.40M(-14.3%) | $18.96M(+26.0%) |
| Jun 2017 | - | $15.06M(-0.4%) |
| Mar 2017 | - | $15.12M(-21.5%) |
| Dec 2016 | - | $19.27M(-2.6%) |
| Sep 2016 | $79.85M(-17.1%) | $19.78M(+2.0%) |
| Jun 2016 | - | $19.38M(-9.0%) |
| Mar 2016 | - | $21.31M(+9.9%) |
| Dec 2015 | - | $19.39M(-23.3%) |
| Sep 2015 | $96.36M(+87.9%) | $25.27M(+56.8%) |
| Jun 2015 | - | $16.12M(-45.7%) |
| Mar 2015 | - | $29.68M(+17.4%) |
| Dec 2014 | - | $25.29M(+25.0%) |
| Sep 2014 | $51.28M(+117.5%) | $20.23M(+58.7%) |
| Jun 2014 | - | $12.74M(+13.2%) |
| Mar 2014 | - | $11.26M(+59.6%) |
| Dec 2013 | - | $7.05M(-12.3%) |
| Sep 2013 | $23.57M(+11.0%) | $8.04M(+56.9%) |
| Jun 2013 | - | $5.13M(-5.7%) |
| Mar 2013 | - | $5.43M(+9.4%) |
| Dec 2012 | - | $4.97M(-8.4%) |
| Sep 2012 | $21.24M | $5.42M(-20.9%) |
| Jun 2012 | - | $6.85M(+39.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $4.90M(+20.6%) |
| Dec 2011 | - | $4.06M(+39.5%) |
| Sep 2011 | $10.13M(+73.6%) | $2.91M(+64.5%) |
| Jun 2011 | - | $1.77M(-2.3%) |
| Mar 2011 | - | $1.81M(-50.1%) |
| Dec 2010 | - | $3.63M(+103.5%) |
| Sep 2010 | $5.83M(-75.0%) | $1.79M(+28.3%) |
| Jun 2010 | - | $1.39M(-0.4%) |
| Mar 2010 | - | $1.40M(-39.5%) |
| Dec 2009 | - | $2.31M(-37.1%) |
| Sep 2009 | $23.32M(-35.8%) | $3.67M(-25.6%) |
| Jun 2009 | - | $4.94M(-9.1%) |
| Mar 2009 | - | $5.43M(-41.5%) |
| Dec 2008 | - | $9.28M(-25.1%) |
| Sep 2008 | $36.31M(-5.5%) | $12.38M(+24.2%) |
| Jun 2008 | - | $9.97M(+34.6%) |
| Mar 2008 | - | $7.41M(+6.4%) |
| Dec 2007 | - | $6.96M(-41.2%) |
| Sep 2007 | $38.43M(+82.3%) | $11.84M(-13.4%) |
| Jun 2007 | - | $13.67M(+62.1%) |
| Mar 2007 | - | $8.44M(+88.1%) |
| Dec 2006 | - | $4.48M(-23.9%) |
| Sep 2006 | $21.08M(+107.0%) | $5.89M(+23.6%) |
| Jun 2006 | - | $4.77M(-20.4%) |
| Mar 2006 | - | $5.99M(+37.2%) |
| Dec 2005 | - | $4.37M(+19.2%) |
| Sep 2005 | $10.18M(+252.7%) | $3.66M(+23.0%) |
| Jun 2005 | - | $2.98M(+70.7%) |
| Mar 2005 | - | $1.75M(-3.4%) |
| Dec 2004 | - | $1.81M(+14.4%) |
| Sep 2004 | $2.89M(+2958.4%) | $1.58M(+149.4%) |
| Jun 2004 | - | $633.20K(+19.1%) |
| Mar 2004 | - | $531.50K(+273.0%) |
| Dec 2003 | - | $142.50K(+850.0%) |
| Sep 2003 | $94.40K(-93.3%) | $15.00K(-2.0%) |
| Jun 2003 | - | $15.30K(-49.5%) |
| Mar 2003 | - | $30.30K(-10.4%) |
| Dec 2002 | - | $33.80K(-97.4%) |
| Sep 2002 | $1.42M(+1197.7%) | $1.32M(+2587.0%) |
| Jun 2002 | - | $49.10K(+113.5%) |
| Mar 2002 | - | $23.00K(-14.8%) |
| Dec 2001 | - | $27.00K(+9.8%) |
| Sep 2001 | $109.30K(-17.2%) | $24.60K(+31.6%) |
| Jun 2001 | - | $18.70K(-27.0%) |
| Mar 2001 | - | $25.60K(-36.6%) |
| Dec 2000 | - | $40.40K(+16.4%) |
| Sep 2000 | $132.00K(+46.0%) | $34.70K(+24.8%) |
| Jun 2000 | - | $27.80K(-12.9%) |
| Mar 2000 | - | $31.90K(-15.4%) |
| Dec 1999 | - | $37.70K |
| Sep 1999 | $90.40K(+15.9%) | - |
| Sep 1998 | $78.00K(-60.6%) | - |
| Sep 1997 | $198.20K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual operating expenses year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly operating expenses year-on-year change?
What is Arrowhead Pharmaceuticals annual total operating expenses?
The current annual operating expenses of ARWR is $604.63M
What is the all time high annual operating expenses for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total operating expenses is $604.63M
What is Arrowhead Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, ARWR annual total operating expenses has changed by +$158.89M (+35.65%)
What is Arrowhead Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of ARWR is $161.51M
What is the all time high quarterly operating expenses for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total operating expenses is $176.14M
What is Arrowhead Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, ARWR quarterly total operating expenses has changed by +$35.32M (+27.99%)